131-Iodine Tositumomab in Lymphoma

Current Oncology - Canada
doi 10.3747/co.v16i5.385
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

MultiMed Inc.

Related search

Tositumomab and Iodine I 131 Tositumomab (Bexaar)

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2011English

Safety and Efficacy of I(131) Tositumomab in the Treatment of Non-Hodgkin's Lymphoma

Clinical Medicine. Therapeutics
2009English

Assessment of Treatment-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia in Patients With Non-Hodgkin Lymphoma Treated With Tositumomab and Iodine I131 Tositumomab

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Iodine-131 and Thyroid Function

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
2014English

Iodine-131 and the Pregnant Patient

American Journal of Roentgenology
MedicineNuclear MedicineRadiologyImaging
2001English

Myeloablative I-131-Tositumomab With Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years With B Cell Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Long-Lived Radioactive Impurities in the Iodine-131 Products

RADIOISOTOPES
1972English

Detection Systems for the Low Level Radiochemical Analysis of Iodine-131, Iodine-129 and Natural Iodine in Environmental Samples

IEEE Transactions on Nuclear Science
Electronic EngineeringNuclearNuclear EnergyHigh Energy PhysicsEngineeringElectrical
1974English

Radioimmunotherapy for B-Cell Lymphoma: Y90 Ibritumomab Tiuxetan and I131 Tositumomab

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy